Dr. Mitchel L. Fromm, MD

Dr. Fromm practices at Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation.

Dr. Fromm's NPI, 1881604817, was assigned on August 9, 2006. Dr. Fromm graduated from Perelman School of Med at the University of Pennsylvania in 1972. Dr. Fromm holds Ohio license 35.053642.

Dr. Fromm's primary practice is Cleveland Clinic Akron General, at 1 Akron General Avenue, Akron, OH 44307 in Summit County. The practice phone is (330) 344-6000.

Dr. Fromm's primary practice is Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Fromm to 5 more medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fromm practices, 2 sites in all. Vendor and product names are available with a free account.

Therapeutic radiology is Dr. Fromm's primary specialty in the NPI Registry, under taxonomy code 2085R0203X. Dr. Fromm is licensed in Ohio.

CMS data shows 421 Medicare services from Dr. Fromm across 6 procedure codes in 2024, for 154 Medicare patients. Medicare paid $26,365 for them.

CMS counts 154 Medicare patients who saw Dr. Fromm in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fromm's median patient age at 69, with 46% women.

In 2024, Dr. Fromm wrote 52 Medicare Part D claims for 31 patients. 96% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $398 in total drug cost. In 2021, CMS named 179 claims across 3 drugs.

Dr. Fromm accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Fromm in 2015. Dr. Fromm's most frequent co-authors are Asha George, MD, Samir Narayan, MD and William F. Regine, MD.

Dmand AI links Dr. Fromm to 10 clinical trials, 6 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Breast Neoplasms and Carcinoma, Lobular. NRG Oncology sponsors the most, 6.

CMS Open Payments shows 7 general payments to Dr. Fromm from 6 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $100.

Dr. Fromm graduated from Perelman School of Med at the University of Pennsylvania in 1972.